Daniel & Daniel Consulting
Country not established
- Devices
- 1
What Daniel & Daniel Consulting makes
Daniel & Daniel Consulting manufactures endoscopic imaging systems, including the Cellvizio 100 Series System and Cellvizio System with confocal miniprobes, as well as flexible cystoscopy devices like the Uroflex B and Cystolflex F. These products are designed for detailed visualization of tissue at the cellular level, primarily in urological and gastrointestinal applications.
The company’s portfolio is classified under FDA’s Class II medical devices and is listed via the 510(k) premarket notification process. These devices are regulated under US jurisdiction, adhering to FDA requirements for endoscopic and imaging technologies.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Daniel & Daniel Consulting have in the registry?
The registry currently lists 1 device for Daniel & Daniel Consulting. Devices recorded under merged duplicate company entries are counted once.
Which registries list Daniel & Daniel Consulting's devices?
Among its 1 most recently registered device, Daniel & Daniel Consulting has devices listed in FDA 510(k) (1 device).
What risk classes do Daniel & Daniel Consulting's devices fall under?
Among its 1 most recently registered device, the classes recorded for Daniel & Daniel Consulting's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Daniel & Daniel Consulting in the registry?
The most recently registered devices listed for Daniel & Daniel Consulting include CELLVIZIO 100 SERIES SYSTEM AND CELLVIZIO SYSTEM WITH CONFOCAL MINIPROBES; UROFLEX B AND CYSTOLFLEX F (BOTH TRADE MARKED.